Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers
Status:
Completed
Trial end date:
2016-12-21
Target enrollment:
Participant gender:
Summary
This double-blind, placebo-controlled, multiple ascending dose study is designed to evaluate
the safety, tolerability, and pharmacokinetics (PK) of SKI-O-703 in healthy volunteers.